Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James Hickman
University of Central Florida, Department: Miscellaneous
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hesperos, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The major innovation of the NIH proposal is the creation of physiologically realistic human in vitro functional units of the CNS and PNS with the proper cell types, cellular interactions and connectivity for application to enable phenotypic screening systems. Hesperos, LLC provides serum-free cellular medium which allows multi-organ system communication for both acute and chronic testing of a compound's toxicity and efficacy. Hesperos, LLC also provides integrated computational modeling of live physiological responses within the chip environment and pumpless body-on-a-chip platform which provides a low cost, low maintenance platform that is readily scalable.
An In Vitro Model of Stem Cell Innervation of Myotubes
Project Narrative The goal of this project is to engineer a system to model one of the most fundamental motor circuits in the human body, the spinal reflex arc and apply it to the neurological disease Amyotrophic Lateral Sclerosis (ALS). We will use nanotechnology and microelectronics in combination with biomedical engineering techniques to build this hybrid biological/non-biological system. Other potential benefits include prevention, diagnosis, and treatment of developmental abnormalities in the spinal cord, rehabilitation of chronic neurological/muscle disorders and accompanying pain, and new strategies for prosthetic and orthotic design and evaluation.
Filed on August 29, 2017.
Tell us what you know about James Hickman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.